A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Rucaparib
The serum concentration of Rucaparib can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Brefeldin A
The serum concentration of Voxilaprevir can be increased when it is combined with Brefeldin A.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Ripretinib
Voxilaprevir may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Estradiol valerate
Estradiol valerate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Estradiol dienanthate
Estradiol dienanthate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Estradiol cypionate
Estradiol cypionate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Estradiol benzoate
Estradiol benzoate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Estradiol acetate
Estradiol acetate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Letermovir
Letermovir may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Testosterone undecanoate
Voxilaprevir may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Testosterone enanthate
Voxilaprevir may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Testosterone cypionate
Voxilaprevir may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Tazemetostat
Voxilaprevir may decrease the excretion rate of Tazemetostat which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Fedratinib
Fedratinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Nabiximols
Nabiximols may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Medical Cannabis
Medical Cannabis may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Gilteritinib
Gilteritinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Voxilaprevir.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Mometasone furoate
The metabolism of Voxilaprevir can be decreased when combined with Mometasone furoate.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Fluticasone
The metabolism of Voxilaprevir can be decreased when combined with Fluticasone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3